Ethico Pharma Private Limited
About Ethico Pharma Private Limited
Data last updated:
Ethico Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 30 December 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24230DL2009PTC197422. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹7 Lakh and a paid-up capital of ₹6 Lakh. It is led by directors including Gagan Bansal and Shubham Bansal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at I – 4/130 First Floor Sector – 16 Rohini, New Delhi, Delhi, India – 110089.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Ethico Pharma Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressI – 4/130 First Floor Sector – 16 Rohini, New Delhi, Delhi, India – 110089
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Ethico Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ethico Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Ethico Pharma Private Limited, buy the company report.
Financials of Ethico Pharma Private Limited
FY 2025 filings availableEthico Pharma Private Limited reported revenue of ₹2,303 (down 100% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 82% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ethico Pharma Private Limited, buy the company report.
Board of directors of Ethico Pharma Private Limited
Ethico Pharma has 3 current directors and 12 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gagan Bansal | Director | 17 Jun 2015 | 11 Years 4 Months | Current |
| Shubham Bansal Also directs: Inventive Medicare (India) LLP, Fibrient Healthcare LLP, VSK Pharma Private Limited and 2 more | Director | 27 Jul 2019 | 7 Years 2 Months | Current |
| Satyam Bansal Also directs: Promenade Lifecare Private Limited | Director | 19 May 2020 | 6 Years 5 Months | Current |
Peer comparison
Ethico Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Genxbio Health Sciences Private Limited | ₹2,906 (FY 2025) | -87.0% | Delhi, India | |||
| German Health Care Private Limited | ₹2,872 (FY 2024) | 884.0% | Indore, Madhya Pradesh, India | |||
| Ethico Pharma Private Limitedthis company | ₹2,303 (FY 2025) | -100.0% | New Delhi, Delhi, India | |||
| Shitaj Healthcare Private Limited | ₹2,017 (FY 2022) | -18.0% | Khaperkheda, Maharashtra, India |
To see the full peer comparison of Ethico Pharma Private Limited, buy the company report.
Auditor
Ethico Pharma Private Limited is audited by DHIRAJ AGGARWAL & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DHIRAJ AGGARWAL & ASSOCIATES | FY 2023 | 036914N |
Shareholding
The shareholding of Ethico Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Ethico Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ethico Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ethico Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ethico Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Ethico Pharma Private Limited, buy the company report.
Recent activity
Ethico Pharma Private Limited has 15 board changes on record since 2013: 3 appointments and 12 cessations. The latest: Satyam Bansal ceased to be Additional Director on 31 Dec 2020.
6 earlier events are in the company report.
Frequently asked questions
Ethico Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 30 December 2009 (17+ years old) and is registered under CIN U24230DL2009PTC197422.
Ethico Pharma has 3 current directors:
- Gagan Bansal - Director
- Shubham Bansal - Director
- Satyam Bansal - Director
The latest financial statements of Ethico Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Ethico Pharma has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Ethico Pharma is U24230DL2009PTC197422. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ethico Pharma was incorporated on 30 December 2009, making it 17+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Ethico Pharma by revenue are Genxbio Health Sciences Private Limited, German Health Care Private Limited, Shitaj Healthcare Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Satyam Bansal ceased to be Additional Director on 31 Dec 2020. Shubham Bansal ceased to be Additional Director on 31 Dec 2020. Ajay Mittal ceased to be Director on 26 Oct 2020. Ethico Pharma has 15 board changes on record in total.
The registered office of Ethico Pharma is at I – 4130 First Floor Sector – 16 Rohini, New Delhi, Delhi, India – 110089.
Ethico Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Ethico Pharma is compliant as of 26 July 2026. The company is actively filing with the Registrar of Companies.